BioTime is moving forward on it’s $53 million deal to purchase stem cell research and development assets from Geron Corporation. (Google Street View)
BioTime, Inc., an Alameda-based biotechnology company, announced today that it has signed a deal with Geron Corporation to acquire intellectual property and other assets related to human embryonic stem cell […]
Recent Comments